Patents by Inventor Tyler Beyett

Tyler Beyett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230212171
    Abstract: The disclosure relates to compounds that act as allosteric inhibitors of epidermal growth factor receptor (EGFR); pharmaceutical compositions comprising the compounds; and methods of treating or preventing kinase-mediated disorders, including cancer and other proliferation diseases.
    Type: Application
    Filed: June 9, 2021
    Publication date: July 6, 2023
    Inventors: David A. Scott, Thomas Gero, Tyler Beyett, David Heppner, Krista E. Gipson, Shih-Chung Huang, Steve Stroud
  • ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20220411404
    Abstract: The disclosure relates to compounds that act as allosteric inhibitors of epidermal growth factor receptor (EGFR); pharmaceutical compositions comprising the compounds; and methods of treating or preventing kinase-mediated disorders, including cancer and other proliferation diseases.
    Type: Application
    Filed: May 10, 2022
    Publication date: December 29, 2022
    Inventors: David A. Scott, David Heppner, Thomas Gero, Courtney A. Cullis, Ciric To, Shih-Chung Huang, Yongbo Hu, Steve Stroud, Tyler Beyett, Michael Eck, Nathanael S. Gray
  • ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20220378757
    Abstract: The disclosure relates to a compound of Formula (I), which acts as an allosteric inhibitor of epidermal growth factor receptor (EGFR); pharmaceutical compositions comprising the compound; and methods of treating or preventing kinase-mediated disorders, including cancer and other proliferation diseases.
    Type: Application
    Filed: June 19, 2020
    Publication date: December 1, 2022
    Inventors: Courtney A. Cullis, Krista E. Gipson, Yongbo Hu, Shih-Chung Huang, Nathanael S. Gray, David A. Scott, Thomas Gero, David Heppner, Tyler Beyett, Ciric To, Michael Eck
  • ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20220233545
    Abstract: The disclosure relates to compounds that act as an allosteric inhibitors of epidermal growth factor receptor (EGFR); pharmaceutical compositions comprising the compounds; and methods of treating or preventing kinase-mediated disorders, including cancer and other proliferation diseases.
    Type: Application
    Filed: June 19, 2020
    Publication date: July 28, 2022
    Inventors: Nathanael S. Gray, David A. Scott, Thomas Gero, Michael Eck, David Heppner, Tyler Beyett, Ciric To